793042 | Di 18:0-N-pSar45—Tetrazine
Di 18:0-N-pSar45—Tetrazine
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
Info
Di 18:0-N-pSar45—Tetrazine
Di 18:0-N-pSar45—Tetrazine
| Polysarcosine (pSar) lipids are offered as alternatives to traditional PEGylated lipids used in RNA delivery vehicles. Compared to similar PEGylated lipid nanoparticles (LNPs), pSar LNPs have shown improved mRNA transfection potency and improved safety profiles. Di 18:0-N-pSar-Tetrazine is a polysarcosine-lipid conjugate that is being studied for its use within drug delivery systems as an alternative to traditional PEGylation in LNPs. The tetrazine moiety allows the molecule to be used in biorthogonal click chemistry. Tetrazine reacts specifically with trans-cyclooctene (TCO) and can occur in complex biological environments without interfering with other biological processes. |
Data
No
No
| C181H306N50O46 |
>99%
1 year
-20°C
3918.74
3916.31